When the tumor was 50–100 mm3, it was injected with rAAV2-AKT2 siRNA or rAAV2-mock siRNA at 109 pfu in 100 μL PBS, and the treatment was repeated three times (once every other day, from day 0). Here, AKT2 is linked to neoplasm.